目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. RSV (Respiratory Syncytial Virus) Vaccines Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. RSV (Respiratory Syncytial Virus) Vaccines Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. RSV (Respiratory Syncytial Virus) Vaccines Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. RSV (Respiratory Syncytial Virus) Vaccines Market: Type Movement Analysis, 2024 & 2030 (USD Million)
4.3. Passive Immunization
4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Preventive Vaccines
4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. RSV (Respiratory Syncytial Virus) Vaccines Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. RSV (Respiratory Syncytial Virus) Vaccines Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
5.3. Monoclonal Antibodies
5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Recombinant Protein + Adjuvant
5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. mRNA-Based Vaccine
5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Virus-Like Particle (VLP)
5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. RSV (Respiratory Syncytial Virus) Vaccines Market: Targeted Population Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. RSV (Respiratory Syncytial Virus) Vaccines Market: Targeted Population Movement Analysis, 2024 & 2030 (USD Million)
6.3. Adults
6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Infants and children
6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. RSV (Respiratory Syncytial Virus) Vaccines Market: Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. RSV (Respiratory Syncytial Virus) Vaccines Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Million)
7.3. Hospital & Retail Pharmacies
7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Government Suppliers
7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Others
7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. RSV (Respiratory Syncytial Virus) Vaccines Market: Regional Estimates & Trend Analysis
8.1. RSV (Respiratory Syncytial Virus) Vaccines Market Share, By Region, 2024 & 2030 (USD Million)
8.2. North America
8.2.1. North America RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. China RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. South Africa RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait RSV (Respiratory Syncytial Virus) Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. AstraZeneca
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Sanofi
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. GSK
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Pfizer Inc.
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Moderna
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Icosavax
9.4.6.1. Financial Performance
9.4.6.2. Product Benchmarking
9.4.6.3. Recent Developments/ Strategic Initiatives
9.4.7. Meissa Vaccines
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Codagenix
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Blue Lake Biotechnology
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Merck & Co., Inc.
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables
Table 1. List of abbreviation
Table 2. Global RSV (Respiratory Syncytial Virus) vaccines market, by region, 2018 - 2030 (USD Million)
Table 3. Global RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 4. Global RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 5. Global RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 6. Global RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 7. North America RSV (Respiratory Syncytial Virus) vaccines market, by country, 2018 - 2030 (USD Million)
Table 8. North America RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 9. North America RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 10. North America RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 11. North America RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 12. U.S. RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 13. U.S. RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 14. U.S. RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 15. U.S. RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 16. Canada RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 17. Canada RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 18. Canada RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 19. Canada RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 20. Mexico RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 21. Mexico RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 22. Mexico RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 23. Mexico RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 24. Europe RSV (Respiratory Syncytial Virus) vaccines market, by country, 2018 - 2030 (USD Million)
Table 25. Europe RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 26. Europe RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 27. Europe RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 28. Europe RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 29. UK RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 30. UK RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 31. UK RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 32. UK RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 33. Germany RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 34. Germany RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 35. Germany RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 36. Germany RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 37. France RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 38. France RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 39. France RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 40. France RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 41. Italy RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 42. Italy RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 43. Italy RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 44. Italy RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 45. Spain RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 46. Spain RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 47. Spain RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 48. Spain RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 49. Denmark RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 50. Denmark RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 51. Denmark RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 52. Denmark RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 53. Sweden RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 54. Sweden RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 55. Sweden RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 56. Sweden RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 57. Norway RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 58. Norway RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 59. Norway RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 60. Norway RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 61. Asia Pacific RSV (Respiratory Syncytial Virus) vaccines market, by country, 2018 - 2030 (USD Million)
Table 62. Asia Pacific RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 63. Asia Pacific RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 64. Asia Pacific RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 65. Asia Pacific RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 66. Japan RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 67. Japan RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 68. Japan RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 69. Japan RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 70. China RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 71. China RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 72. China RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 73. China RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 74. India RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 75. India RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 76. India RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 77. India RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 78. Australia RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 79. Australia RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 80. Australia RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 81. Australia RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 82. South Korea RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 83. South Korea RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 84. South Korea RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 85. South Korea RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 86. Thailand RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 87. Thailand RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 88. Thailand RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 89. Thailand RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 90. Latin America RSV (Respiratory Syncytial Virus) vaccines market, by country, 2018 - 2030 (USD Million)
Table 91. Latin America RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 92. Latin America RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 93. Latin America RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 94. Latin America RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 95. Brazil RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 96. Brazil RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 97. Brazil RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 98. Brazil RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 99. Argentina RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 100. Argentina RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 101. Argentina RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 102. Argentina RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 103. MEA RSV (Respiratory Syncytial Virus) vaccines market, by country, 2018 - 2030 (USD Million)
Table 104. MEA RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 105. MEA RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 106. MEA RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 107. MEA RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 108. South Africa RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 109. South Africa RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 110. South Africa RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 111. South Africa RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 112. Saudi Arabia RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 113. Saudi Arabia RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 114. Saudi Arabia RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 115. Saudi Arabia RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 116. UAE RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 117. UAE RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 118. UAE RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 119. UAE RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)
Table 120. Kuwait RSV (Respiratory Syncytial Virus) vaccines market, by product, 2018 - 2030 (USD Million)
Table 121. Kuwait RSV (Respiratory Syncytial Virus) vaccines market, by technology, 2018 - 2030 (USD Million)
Table 122. Kuwait RSV (Respiratory Syncytial Virus) vaccines market, by targeted population, 2018 - 2030 (USD Million)
Table 123. Kuwait RSV (Respiratory Syncytial Virus) vaccines market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 RSV (Respiratory Syncytial Virus) vaccines market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 RSV (Respiratory Syncytial Virus) vaccines market: Product outlook key takeaways
Fig. 20 RSV (Respiratory Syncytial Virus) vaccines market: Type movement analysis
Fig. 21 Passive immunization market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Preventive vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 RSV (Respiratory Syncytial Virus) vaccines market: Technology outlook key takeaways
Fig. 24 RSV (Respiratory Syncytial Virus) vaccines market: Technology movement analysis
Fig. 25 Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Recombinant Protein + Adjuvant market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 mRNA-based vaccine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 RSV (Respiratory Syncytial Virus) vaccines market: Targeted Population outlook key takeaways
Fig. 29 RSV (Respiratory Syncytial Virus) vaccines market: Targeted Population movement analysis
Fig. 30 Adults market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Infants and children market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 RSV (Respiratory Syncytial Virus) vaccines market: Distribution Channel outlook key takeaways
Fig. 33 RSV (Respiratory Syncytial Virus) vaccines market: Distribution Channel movement analysis
Fig. 34 Hospital & retail pharmacies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Government suppliers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Regional marketplace outlook, 2024 & 2030 (USD million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 North America RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Key country dynamics
Fig. 41 US RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Key country dynamics
Fig. 43 Canada RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Key country dynamics
Fig. 45 Mexico RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Europe RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 UK RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Germany RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 France RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Spain RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Italy RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Denmark RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Sweden RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Norway RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Asia Pacific RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Japan RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 China RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 India RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Australia RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 South Korea RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Thailand RSV (Respiratory Syncytial Virus) vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Market participant categorization
Fig. 78 RSV (Respiratory Syncytial Virus) vaccines market position analysis, 2024
Fig. 79 Strategic framework